A	A	DT	B-NP	O		0	1
novel	novel	JJ	I-NP	O		2	7
receptor	receptor	NN	I-NP	O		8	16
-	-	HYPH	B-NP	O		17	18
ligand	ligand	NN	I-NP	O		19	25
pathway	pathway	NN	I-NP	O		26	33
for	for	IN	B-PP	O		34	37
entry	entry	NN	B-NP	O		38	43
of	of	IN	B-PP	O		44	46
Francisella tularensis	Francisella_tularensis	NNP	B-NP	O		47	69
in	in	IN	B-PP	O		70	72
monocyte	monocyte	NN	B-NP	B-cell_type		73	81
-	-	HYPH	B-NP	O		81	82
like	like	JJ	I-NP	O		82	86
THP	THP	NN	I-NP	O		87	90
-1	-1	NN	I-NP	O		90	92
cells	cell	NNS	I-NP	O		93	98
:	:	:	O	O		98	99
interaction	interaction	NN	B-NP	O		100	111
between	between	IN	B-PP	O		112	119
surface	surface	NN	B-NP	B-protein		120	127
nucleolin	nucleolin	NN	I-NP	I-protein		128	137
and	and	CC	O	O		138	141
bacterial	bacterial	JJ	B-NP	B-protein		142	151
elongation	elongation	NN	I-NP	I-protein		152	162
factor	factor	NN	I-NP	I-protein		163	169
Tu	Tu	NN	I-NP	O		170	172
.	.	.	O	O		172	173

Francisella tularensis	Francisella_tularensis	NNP	B-NP	O		174	196
,	,	,	O	O		196	197
the	the	DT	B-NP	O		198	201
causative	causative	JJ	I-NP	O		202	211
agent	agent	NN	I-NP	O		212	217
of	of	IN	B-PP	O		218	220
tularemia	tularemia	NN	B-NP	O		221	230
,	,	,	O	O		230	231
is	be	VBZ	B-VP	O		232	234
one	one	CD	B-NP	O		235	238
of	of	IN	B-PP	O		239	241
the	the	DT	B-NP	O		242	245
most	most	RBS	I-NP	O		246	250
infectious	infectious	JJ	I-NP	O		251	261
human	human	JJ	I-NP	O		262	267
bacterial	bacterial	JJ	I-NP	O		268	277
pathogens	pathogen	NNS	I-NP	O		278	287
.	.	.	O	O		287	288

It	It	PRP	B-NP	O		289	291
is	be	VBZ	B-VP	O		292	294
phagocytosed	phagocytose	VBN	I-VP	O		295	307
by	by	IN	B-PP	O		308	310
immune	immune	JJ	B-NP	B-cell_type		311	317
cells	cell	NNS	I-NP	I-cell_type		318	323
,	,	,	O	O		323	324
such	such	JJ	B-PP	O		325	329
as	as	IN	I-PP	O		330	332
monocytes	monocyte	NNS	B-NP	B-cell_type		333	342
and	and	CC	O	O		343	346
macrophages	macrophage	NNS	B-NP	B-cell_type		347	358
.	.	.	O	O		358	359

The	The	DT	B-NP	O		360	363
precise	precise	JJ	I-NP	O		364	371
mechanisms	mechanism	NNS	I-NP	O		372	382
that	that	WDT	B-NP	O		383	387
initiate	initiate	VBP	B-VP	O		388	396
bacterial	bacterial	JJ	B-NP	O		397	406
uptake	uptake	NN	I-NP	O		407	413
have	have	VBP	B-VP	O		414	418
not	not	RB	I-VP	O		419	422
yet	yet	RB	I-VP	O		423	426
been	be	VBN	I-VP	O		427	431
elucidated	elucidate	VBN	I-VP	O		432	442
.	.	.	O	O		442	443

Participation	Participation	NN	B-NP	O		444	457
of	of	IN	B-PP	O		458	460
C3	C3	NN	B-NP	B-protein		461	463
,	,	,	O	O		463	464
CR3	CR3	NN	B-NP	B-protein		465	468
,	,	,	O	O		468	469
class	class	NN	B-NP	B-protein		470	475
A	A	NN	I-NP	I-protein		476	477
scavenger	scavenger	NN	I-NP	I-protein		478	487
receptors	receptor	NNS	I-NP	I-protein		488	497
and	and	CC	O	O		498	501
mannose	mannose	NN	B-NP	B-protein		502	509
receptor	receptor	NN	I-NP	I-protein		510	518
in	in	IN	B-PP	O		519	521
bacterial	bacterial	JJ	B-NP	O		522	531
uptake	uptake	NN	I-NP	O		532	538
have	have	VBP	B-VP	O		539	543
been	be	VBN	I-VP	O		544	548
already	already	RB	I-VP	O		549	556
reported	report	VBN	I-VP	O		557	565
.	.	.	O	O		565	566

However	However	RB	B-ADVP	O		567	574
,	,	,	O	O		574	575
contribution	contribution	NN	B-NP	O		576	588
of	of	IN	B-PP	O		589	591
an	an	DT	B-NP	O		592	594
additional	additional	JJ	I-NP	O		595	605
,	,	,	I-NP	O		605	606
as-yet	as-yet	RB	I-NP	O		607	613
-	-	HYPH	I-NP	O		613	614
unidentified	unidentified	JJ	I-NP	O		614	626
receptor	receptor	NN	I-NP	O		627	635
for	for	IN	B-PP	O		636	639
F. tularensis	F._tularensis	NN	B-NP	O		640	653
internalization	internalization	NN	I-NP	O		654	669
has	have	VBZ	B-VP	O		670	673
been	be	VBN	I-VP	O		674	678
suggested	suggest	VBN	I-VP	O		679	688
.	.	.	O	O		688	689

We	We	PRP	B-NP	O		690	692
show	show	VBP	B-VP	O		693	697
here	here	RB	B-ADVP	O		698	702
that	that	IN	B-SBAR	O		703	707
cell	cell	NN	B-NP	O		708	712
-	-	HYPH	I-NP	O		712	713
surface	surface	NN	I-NP	O		713	720
expressed	express	VBN	I-NP	O		721	730
nucleolin	nucleolin	NN	I-NP	B-protein		731	740
is	be	VBZ	B-VP	O		741	743
a	a	DT	B-NP	O		744	745
receptor	receptor	NN	I-NP	O		746	754
for	for	IN	B-PP	O		755	758
Francisella tularensis	Francisella_tularensis	NNP	B-NP	O		759	781
Live	Live	NNP	I-NP	O		782	786
Vaccine	Vaccine	NNP	I-NP	O		787	794
Strain	Strain	NNP	I-NP	O		795	801
(	(	(	O	O		802	803
LVS	LVS	NNP	B-NP	O		803	806
)	)	)	O	O		806	807
and	and	CC	O	O		808	811
promotes	promote	VBZ	B-VP	O		812	820
LVS	LVS	NN	B-NP	O		821	824
binding	binding	NN	I-NP	O		825	832
and	and	CC	I-NP	O		833	836
infection	infection	NN	I-NP	O		837	846
of	of	IN	B-PP	O		847	849
human	human	JJ	B-NP	B-cell_line		850	855
monocyte	monocyte	NN	I-NP	I-cell_line		856	864
-	-	HYPH	B-NP	I-cell_line		864	865
like	like	JJ	I-NP	I-cell_line		865	869
THP	THP	NN	I-NP	I-cell_line		870	873
-1	-1	NN	I-NP	I-cell_line		873	875
cells	cell	NNS	I-NP	I-cell_line		876	881
.	.	.	O	O		881	882

The	The	DT	B-NP	O		883	886
HB	HB	NN	I-NP	O		887	889
-19	-19	CD	I-NP	O		889	892
pseudopeptide	pseudopeptide	NN	I-NP	O		893	906
that	that	WDT	B-NP	O		907	911
binds	bind	VBZ	B-VP	O		912	917
specifically	specifically	RB	B-ADVP	O		918	930
carboxy	carboxy	AFX	B-NP	B-protein		931	938
-	-	HYPH	I-NP	I-protein		938	939
terminal	terminal	JJ	I-NP	I-protein		939	947
RGG	RGG	NN	I-NP	I-protein		948	951
domain	domain	NN	I-NP	I-protein		952	958
of	of	IN	B-PP	O		959	961
nucleolin	nucleolin	NN	B-NP	B-protein		962	971
inhibits	inhibit	VBZ	B-VP	O		972	980
LVS	LVS	NN	B-NP	O		981	984
binding	binding	NN	I-NP	O		985	992
and	and	CC	I-NP	O		993	996
infection	infection	NN	I-NP	O		997	1006
of	of	IN	B-PP	O		1007	1009
monocyte	monocyte	NN	B-NP	B-cell_type		1010	1018
-	-	HYPH	B-NP	O		1018	1019
like	like	JJ	I-NP	O		1019	1023
THP	THP	NN	I-NP	O		1024	1027
-1	-1	NN	I-NP	O		1027	1029
cells	cell	NNS	I-NP	O		1030	1035
.	.	.	O	O		1035	1036

In	In	IN	B-PP	O		1037	1039
a	a	DT	B-NP	O		1040	1041
pull	pull	VB	I-NP	O		1042	1046
-	-	HYPH	B-VP	O		1046	1047
down	down	RP	B-PRT	O		1047	1051
assay	assay	NN	B-NP	O		1052	1057
,	,	,	O	O		1057	1058
elongation	elongation	NN	B-NP	B-protein		1059	1069
factor	factor	NN	I-NP	I-protein		1070	1076
Tu	Tu	NN	I-NP	O		1077	1079
(	(	(	O	O		1080	1081
EF	EF	NN	B-NP	B-protein		1081	1083
-	-	HYPH	B-NP	O		1083	1084
Tu	Tu	NN	I-NP	O		1084	1086
)	)	)	O	O		1086	1087
,	,	,	O	O		1087	1088
a	a	DT	B-NP	O		1089	1090
GTP	GTP	NN	I-NP	B-protein		1091	1094
-	-	HYPH	O	I-protein		1094	1095
binding	bind	VBG	B-NP	I-protein		1095	1102
protein	protein	NN	I-NP	I-protein		1103	1110
involved	involve	VBN	B-VP	O		1111	1119
in	in	IN	B-PP	O		1120	1122
protein	protein	NN	B-NP	O		1123	1130
translation	translation	NN	I-NP	O		1131	1142
,	,	,	O	O		1142	1143
usually	usually	RB	B-VP	O		1144	1151
found	find	VBN	I-VP	O		1152	1157
in	in	IN	B-PP	O		1158	1160
cytoplasm	cytoplasm	NN	B-NP	O		1161	1170
,	,	,	O	O		1170	1171
was	be	VBD	B-VP	O		1172	1175
recovered	recover	VBN	I-VP	O		1176	1185
among	among	IN	B-PP	O		1186	1191
LVS	LVS	NN	B-NP	B-protein		1192	1195
bacterial	bacterial	JJ	I-NP	I-protein		1196	1205
membrane	membrane	NN	I-NP	I-protein		1206	1214
proteins	protein	NNS	I-NP	I-protein		1215	1223
bound	bind	VBN	B-VP	O		1224	1229
on	on	IN	B-PP	O		1230	1232
RGG	RGG	NN	B-NP	B-protein		1233	1236
domain	domain	NN	I-NP	I-protein		1237	1243
of	of	IN	B-PP	O		1244	1246
nucleolin	nucleolin	NN	B-NP	B-protein		1247	1256
.	.	.	O	O		1256	1257

A	A	DT	B-NP	O		1258	1259
specific	specific	JJ	I-NP	O		1260	1268
polyclonal	polyclonal	JJ	I-NP	O		1269	1279
murine	murine	JJ	I-NP	B-protein		1280	1286
antibody	antibody	NN	I-NP	I-protein		1287	1295
was	be	VBD	B-VP	O		1296	1299
raised	raise	VBN	I-VP	O		1300	1306
against	against	IN	B-PP	O		1307	1314
recombinant	recombinant	JJ	B-NP	B-protein		1315	1326
LVS	LVS	NN	I-NP	I-protein		1327	1330
EF	EF	NN	I-NP	I-protein		1331	1333
-	-	HYPH	B-NP	O		1333	1334
Tu	Tu	NN	I-NP	O		1334	1336
.	.	.	O	O		1336	1337

By	By	IN	B-PP	O		1338	1340
fluorescence	fluorescence	NN	B-NP	O		1341	1353
and	and	CC	O	O		1354	1357
electron	electron	NN	B-NP	O		1358	1366
microscopy	microscopy	NN	I-NP	O		1367	1377
experiments	experiment	NNS	I-NP	O		1378	1389
,	,	,	O	O		1389	1390
we	we	PRP	B-NP	O		1391	1393
found	find	VBD	B-VP	O		1394	1399
that	that	IN	B-SBAR	O		1400	1404
a	a	DT	B-NP	O		1405	1406
fraction	fraction	NN	I-NP	O		1407	1415
of	of	IN	B-PP	O		1416	1418
EF	EF	NN	B-NP	B-protein		1419	1421
-	-	HYPH	O	O		1421	1422
Tu	Tu	NN	B-NP	O		1422	1424
could	could	MD	B-VP	O		1425	1430
be	be	VB	I-VP	O		1431	1433
detected	detect	VBN	I-VP	O		1434	1442
at	at	IN	B-PP	O		1443	1445
the	the	DT	B-NP	O		1446	1449
bacterial	bacterial	JJ	I-NP	O		1450	1459
surface	surface	NN	I-NP	O		1460	1467
.	.	.	O	O		1467	1468

Anti	Anti	AFX	B-NP	O		1469	1473
-	-	HYPH	I-NP	B-protein		1473	1474
EF	EF	NN	I-NP	I-protein		1474	1476
-	-	HYPH	I-NP	O		1476	1477
Tu	Tu	NN	I-NP	B-protein		1477	1479
antibodies	antibody	NNS	I-NP	I-protein		1480	1490
reduced	reduce	VBD	B-VP	O		1491	1498
LVS	LVS	NN	B-NP	O		1499	1502
binding	binding	NN	I-NP	O		1503	1510
to	to	TO	B-PP	O		1511	1513
monocyte	monocyte	NN	B-NP	B-cell_type		1514	1522
-	-	HYPH	B-NP	O		1522	1523
like	like	JJ	I-NP	O		1523	1527
THP	THP	NN	I-NP	O		1528	1531
-1	-1	NN	I-NP	O		1531	1533
cells	cell	NNS	I-NP	O		1534	1539
and	and	CC	O	O		1540	1543
impaired	impaired	JJ	B-NP	O		1544	1552
infection	infection	NN	I-NP	O		1553	1562
,	,	,	O	O		1562	1563
even	even	RB	B-ADVP	O		1564	1568
in	in	IN	B-PP	O		1569	1571
absence	absence	NN	B-NP	O		1572	1579
of	of	IN	B-PP	O		1580	1582
complement	complement	NN	B-NP	O		1583	1593
and	and	CC	I-NP	O		1594	1597
complement	complement	NN	I-NP	B-protein		1598	1608
receptors	receptor	NNS	I-NP	I-protein		1609	1618
.	.	.	O	O		1618	1619

Interaction	Interaction	NN	B-NP	O		1620	1631
between	between	IN	B-PP	O		1632	1639
EF	EF	NN	B-NP	B-protein		1640	1642
-	-	HYPH	I-NP	O		1642	1643
Tu	Tu	NN	I-NP	O		1643	1645
and	and	CC	I-NP	O		1646	1649
nucleolin	nucleolin	NN	I-NP	B-protein		1650	1659
was	be	VBD	B-VP	O		1660	1663
illustrated	illustrate	VBN	I-VP	O		1664	1675
by	by	IN	B-PP	O		1676	1678
two	two	CD	B-NP	O		1679	1682
different	different	JJ	I-NP	O		1683	1692
pull	pull	NN	I-NP	O		1693	1697
-	-	HYPH	B-VP	O		1697	1698
down	down	RP	B-PRT	O		1698	1702
assays	assay	NNS	B-NP	O		1703	1709
using	use	VBG	B-VP	O		1710	1715
recombinant	recombinant	JJ	B-NP	B-protein		1716	1727
EF	EF	NN	I-NP	I-protein		1728	1730
-	-	HYPH	I-NP	I-protein		1730	1731
Tu	Tu	NN	I-NP	I-protein		1731	1733
proteins	protein	NNS	I-NP	I-protein		1734	1742
and	and	CC	O	O		1743	1746
either	either	CC	O	O		1747	1753
RGG	RGG	NN	B-NP	B-protein		1754	1757
domain	domain	NN	I-NP	I-protein		1758	1764
of	of	IN	B-PP	O		1765	1767
nucleolin	nucleolin	NN	B-NP	B-protein		1768	1777
or	or	CC	I-NP	O		1778	1780
cell	cell	NN	I-NP	O		1781	1785
solubilized	solubilize	VBD	B-VP	O		1786	1797
nucleolin	nucleolin	NN	B-NP	B-protein		1798	1807
.	.	.	O	O		1807	1808

Altogether	Altogether	RB	B-ADVP	O		1809	1819
,	,	,	O	O		1819	1820
our	our	PRP$	B-NP	O		1821	1824
results	result	NNS	I-NP	O		1825	1832
demonstrate	demonstrate	VBP	B-VP	O		1833	1844
that	that	IN	B-SBAR	O		1845	1849
the	the	DT	B-NP	O		1850	1853
interaction	interaction	NN	I-NP	O		1854	1865
between	between	IN	B-PP	O		1866	1873
surface	surface	NN	B-NP	B-protein		1874	1881
nucleolin	nucleolin	NN	I-NP	I-protein		1882	1891
and	and	CC	O	O		1892	1895
its	its	PRP$	B-NP	O		1896	1899
bacterial	bacterial	JJ	I-NP	B-protein		1900	1909
ligand	ligand	NN	I-NP	I-protein		1910	1916
EF	EF	NN	I-NP	I-protein		1917	1919
-	-	HYPH	B-NP	O		1919	1920
Tu	Tu	NN	I-NP	O		1920	1922
plays	play	VBZ	B-VP	O		1923	1928
an	an	DT	B-NP	O		1929	1931
important	important	JJ	I-NP	O		1932	1941
role	role	NN	I-NP	O		1942	1946
in	in	IN	B-PP	O		1947	1949
Francisella tularensis	Francisella_tularensis	NNP	B-NP	O		1950	1972
adhesion	adhesion	NN	I-NP	O		1973	1981
and	and	CC	I-NP	O		1982	1985
entry	entry	NN	I-NP	O		1986	1991
process	process	NN	I-NP	O		1992	1999
and	and	CC	O	O		2000	2003
may	may	MD	B-VP	O		2004	2007
therefore	therefore	RB	I-VP	O		2008	2017
facilitate	facilitate	VB	I-VP	O		2018	2028
invasion	invasion	NN	B-NP	O		2029	2037
of	of	IN	B-PP	O		2038	2040
host	host	NN	B-NP	O		2041	2045
tissues	tissue	NNS	I-NP	O		2046	2053
.	.	.	O	O		2053	2054

Since	Since	IN	B-SBAR	O		2055	2060
phagosomal	phagosomal	JJ	B-NP	O		2061	2071
escape	escape	NN	I-NP	O		2072	2078
and	and	CC	O	O		2079	2082
intra	intra	AFX	B-NP	O		2083	2088
-	-	HYPH	I-NP	O		2088	2089
cytosolic	cytosolic	JJ	I-NP	O		2089	2098
multiplication	multiplication	NN	I-NP	O		2099	2113
of	of	IN	B-PP	O		2114	2116
LVS	LVS	NN	B-NP	B-protein		2117	2120
in	in	IN	B-PP	O		2121	2123
infected	infected	JJ	B-NP	B-cell_type		2124	2132
monocytes	monocyte	NNS	I-NP	I-cell_type		2133	2142
are	be	VBP	B-VP	O		2143	2146
very	very	RB	B-ADJP	O		2147	2151
similar	similar	JJ	I-ADJP	O		2152	2159
to	to	TO	B-PP	O		2160	2162
those	those	DT	B-NP	O		2163	2168
of	of	IN	B-PP	O		2169	2171
human	human	JJ	B-NP	O		2172	2177
pathogenic	pathogenic	JJ	I-NP	O		2178	2188
F. tularensis	F._tularensis	NN	I-NP	O		2189	2202
ssp	ssp	NN	I-NP	O		2203	2206
tularensis	tularensis	NN	I-NP	O		2207	2217
,	,	,	O	O		2217	2218
the	the	DT	B-NP	O		2219	2222
mechanism	mechanism	NN	I-NP	O		2223	2232
of	of	IN	B-PP	O		2233	2235
entry	entry	NN	B-NP	O		2236	2241
into	into	IN	B-PP	O		2242	2246
monocyte	monocyte	NN	B-NP	B-cell_type		2247	2255
-	-	HYPH	B-NP	O		2255	2256
like	like	JJ	I-NP	O		2256	2260
THP	THP	NN	I-NP	O		2261	2264
-1	-1	NN	I-NP	O		2264	2266
cells	cell	NNS	I-NP	O		2267	2272
,	,	,	O	O		2272	2273
involving	involve	VBG	B-VP	O		2274	2283
interaction	interaction	NN	B-NP	O		2284	2295
between	between	IN	B-PP	O		2296	2303
EF	EF	NN	B-NP	B-protein		2304	2306
-	-	HYPH	I-NP	O		2306	2307
Tu	Tu	NN	I-NP	O		2307	2309
and	and	CC	I-NP	O		2310	2313
nucleolin	nucleolin	NN	I-NP	B-protein		2314	2323
,	,	,	O	O		2323	2324
might	might	MD	B-VP	O		2325	2330
be	be	VB	I-VP	O		2331	2333
similar	similar	JJ	B-ADJP	O		2334	2341
in	in	IN	B-PP	O		2342	2344
the	the	DT	B-NP	O		2345	2348
two	two	CD	I-NP	O		2349	2352
subspecies	subspecy	NNS	I-NP	O		2353	2363
.	.	.	O	O		2363	2364

Thus	Thus	RB	B-ADVP	O		2365	2369
,	,	,	O	O		2369	2370
the	the	DT	B-NP	O		2371	2374
use	use	NN	I-NP	O		2375	2378
of	of	IN	B-PP	O		2379	2381
either	either	CC	O	O		2382	2388
nucleolin	nucleolin	NN	B-NP	B-protein		2389	2398
-	-	HYPH	B-NP	O		2398	2399
specific	specific	JJ	I-NP	O		2399	2407
pseudopeptide	pseudopeptide	NN	I-NP	O		2408	2421
HB	HB	NN	I-NP	O		2422	2424
-19	-19	CD	I-NP	O		2424	2427
or	or	CC	O	O		2428	2430
recombinant	recombinant	JJ	B-NP	B-protein		2431	2442
EF	EF	NN	I-NP	I-protein		2443	2445
-	-	HYPH	B-NP	O		2445	2446
Tu	Tu	NN	I-NP	O		2446	2448
could	could	MD	B-VP	O		2449	2454
provide	provide	VB	I-VP	O		2455	2462
attractive	attractive	JJ	B-NP	O		2463	2473
therapeutic	therapeutic	JJ	I-NP	O		2474	2485
approaches	approach	NNS	I-NP	O		2486	2496
for	for	IN	B-PP	O		2497	2500
modulating	modulate	VBG	B-VP	O		2501	2511
F. tularensis	F._tularensis	NNP	B-NP	O		2512	2525
infection	infection	NN	I-NP	O		2526	2535
.	.	.	O	O		2535	2536

